ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Washington » General Practice

Top General Practice Prescribers in Washington

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MARIA LYDIA MONTENEGRO MD

General Practice

13,223

$827K

207
38 are 65+

15%
patients receiving schedule two controlled substances

Avg: 7%

8%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$63
Average prescription price

Avg: $50

THU LE MD

General Practice

9,019

$416K

242
223 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$46
Average prescription price

Avg: $50

EFREN CARATAO M.D.

General Practice

8,552

$279K

205
192 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

8%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$33
Average prescription price

Avg: $50

FRANK HING MD

General Practice

8,254

$373K

294
242 are 65+

11%
patients receiving schedule two controlled substances

Avg: 7%

26%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$45
Average prescription price

Avg: $50

ROBERT KUHNS DO

General Practice

7,566

$382K

401
351 are 65+

13%
patients receiving schedule two controlled substances

Avg: 7%

16%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$51
Average prescription price

Avg: $50

DUNG NGUYEN MD

General Practice

7,183

$184K

267
237 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

18%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 24%

$26
Average prescription price

Avg: $50

JACK TACKER M.D.

General Practice

7,180

$307K

366
320 are 65+

34%
patients receiving schedule two controlled substances

Avg: 7%

15%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$43
Average prescription price

Avg: $50

ELLA BOSTANJIAN M.D.

General Practice

6,825

$321K

190
158 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

9%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 24%

$47
Average prescription price

Avg: $50

WALLACE DONALDSON M.D.

General Practice

6,226

$270K

172
127 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

28%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$43
Average prescription price

Avg: $50

GENE LIAW M.D.

General Practice

5,720

$216K

213
203 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

8%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$38
Average prescription price

Avg: $50

WAJAHAT KHAN M.D.

General Practice

5,181

$311K

504
427 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

11%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$60
Average prescription price

Avg: $50

DAVID LITTLE DO

General Practice

4,971

$243K

322
110 are 65+

13%
patients receiving schedule two controlled substances

Avg: 7%

14%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$49
Average prescription price

Avg: $50

LEYTON JUMP

General Practice

4,674

$263K

215
160 are 65+

10%
patients receiving schedule two controlled substances

Avg: 7%

13%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$56
Average prescription price

Avg: $50

CHARLES CHAFFEE MD

General Practice

4,580

$180K

283
233 are 65+

9%
patients receiving schedule two controlled substances

Avg: 7%

13%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$39
Average prescription price

Avg: $50

AMIRA MORCOS MD

General Practice

4,467

$280K

217
175 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

7%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 24%

$63
Average prescription price

Avg: $50

PUSHPA RAM MD

General Practice

4,235

$284K

196
35 are 65+

12%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$67
Average prescription price

Avg: $50

HERB JOHNSON D.O.

General Practice

4,043

$225K

193
166 are 65+

7%
patients receiving schedule two controlled substances

Avg: 7%

24%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 24%

$56
Average prescription price

Avg: $50

GILBERT ESCANDON MD

General Practice

4,042

$219K

326
282 are 65+

6%
patients receiving schedule two controlled substances

Avg: 7%

14%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$54
Average prescription price

Avg: $50

GEORGE GARFEIN MD

General Practice

3,806

$185K

193
175 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

15%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$49
Average prescription price

Avg: $50

ANDREA OPALENIK DO

General Practice

3,711

$208K

236
90 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

5%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$56
Average prescription price

Avg: $50

ANDREW TSOI MD

General Practice

3,535

$151K

650
428 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

0%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$43
Average prescription price

Avg: $50

CECIL SNODGRASS M.D.

General Practice

3,393

$186K

177
145 are 65+

8%
patients receiving schedule two controlled substances

Avg: 7%

20%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 24%

$55
Average prescription price

Avg: $50

CRAIG BREWER MD

General Practice

3,244

$199K

177
171 are 65+

0%
patients receiving schedule two controlled substances

Avg: 7%

9%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$61
Average prescription price

Avg: $50

PATRICIA O'ROURKE M.D.

General Practice

3,194

$225K

86
40 are 65+

35%
patients receiving schedule two controlled substances

Avg: 7%

37%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$70
Average prescription price

Avg: $50

KHUSHBOO MEHTA

General Practice

3,147

$104K

319
287 are 65+

9%
patients receiving schedule two controlled substances

Avg: 7%

14%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$33
Average prescription price

Avg: $50

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank